Biovie (BIVI) Other Operating Expenses (2013 - 2026)
Biovie (BIVI) reported Other Operating Expenses of $6,308 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 89.1% from $57,641 a year earlier and down 89.0% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Other Operating Expenses (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Biovie posted Other Operating Expenses of $178,341, down 22.2% from FY2025.
- Other Operating Expenses has a five-year compound annual growth rate of -73.3% (FY2021 to FY2026).
- By fiscal year, Other Operating Expenses came in at $229,377 in FY2025, $5,215 in FY2024 (-97.7%), $229,377 in FY2023 (unchanged) and $229,377 in FY2022 (-99.8%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Other Operating Expenses since fiscal Q3 2024.
- Year over year, Other Operating Expenses gained in three of the last eight quarters, with growth averaging 113.9%.
- The high point for year-over-year Other Operating Expenses in five years was fiscal Q3 2025 (growth of 999.6%); the low point was fiscal Q4 2022 (a decline of 100.0%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $57,344 (Q3 2026), $57,344 (Q2 2026) and $57,225 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,308.00 |
| Mar 31, 2026 | 57,344.00 |
| Dec 31, 2025 | 57,344.00 |
| Sep 30, 2025 | 57,225.00 |
| Jun 30, 2025 | 57,641.00 |
| Mar 31, 2025 | 57,344.00 |
| Dec 31, 2024 | 57,344.00 |
| Sep 30, 2024 | 56,884.00 |
| Jun 30, 2024 | 57,158.00 |
| Mar 31, 2024 | 5,215.00 |
| Dec 31, 2023 | 57,344.00 |
| Sep 30, 2023 | 57,344.00 |
| Jun 30, 2023 | 57,344.00 |
| Mar 31, 2023 | 57,344.00 |
| Dec 31, 2022 | 57,344.00 |
| Sep 30, 2022 | 57,344.00 |
| Jun 30, 2022 | 57,345.00 |
| Mar 31, 2022 | 57,344.00 |
| Dec 31, 2021 | 57,344.00 |
| Sep 30, 2021 | 57,344.00 |
API Access
Biovie Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();